We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+23.32%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
-$11.8M
Cap. Flow
+$77.2M
Cap. Flow %
6.76%
Top 10 Hldgs %
64.3%
Holding
85
New
15
Increased
23
Reduced
19
Closed
17
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
1 year
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
1.2 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$51.9M
2
CTLT icon
CATALENT, INC.
CTLT
+$37.6M
3
SNY icon
Sanofi
SNY
+$26.7M
4
BIIB icon
Biogen
BIIB
+$21.8M
5
GSK icon
GSK
GSK
+$18.4M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$96.3M
2
CYH icon
Community Health Systems
CYH
+$21M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$17M
4
LNTH icon
Lantheus
LNTH
+$14.6M
5
ABMD
Abiomed Inc
ABMD
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 89.7%
2 Miscellaneous 9.48%
3 Communication Services 0.77%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RGEN icon
26
Repligen
RGEN
$11.1B
$9.65M 0.85%
57,004
+53,363
+1,466% +$9.68M
2021 Q1
7 quarters
IONS icon
27
Ionis Pharmaceuticals
IONS
$7.14B
$9.1M 0.8%
240,975
+39,142
+19% +$1.65M
2021 Q2
6 quarters
MODN icon
28
DELISTED
MODEL N, INC.
MODN
$8.84M 0.77%
+217,880
New +$8.2M
2022 Q4
0 quarters
CYH icon
29
Community Health Systems
CYH
$406M
$8.65M 0.76%
2,001,994
-6,839,610
-77% -$21M
2020 Q4
8 quarters
PCVX icon
30
Vaxcyte
PCVX
$10B
$8.56M 0.75%
+178,453
New +$7M
2022 Q4
0 quarters
LQDA icon
31
Liquidia Corp
LQDA
$3.07B
$8.22M 0.72%
1,290,913
-110,530
-8% -$594K
2021 Q1
7 quarters
APLS icon
32
DELISTED
Apellis Pharmaceuticals
APLS
$8M 0.7%
+154,796
New +$8.21M
2022 Q4
0 quarters
VERA icon
33
Vera Therapeutics
VERA
$2.01B
$7.96M 0.7%
411,308
+255,179
+163% +$4.62M
2022 Q3
1 quarter
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.51M 0.66%
+350,747
New +$7.49M
2022 Q4
0 quarters
XBI icon
35
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.54B
$7.47M 0.65%
90,000
– –
2022 Q2
2 quarters
TARO icon
36
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$6.55M 0.57%
225,462
+2,079
+0.9% +$61.7K
2019 Q4
12 quarters
PBYI icon
37
Puma Biotechnology
PBYI
$507M
$6.38M 0.56%
1,507,663
+1,958
+0.1% +$6.76K
2021 Q3
5 quarters
MRK icon
38
CALL
Merck
MRK
$360B
$5.4M 0.47%
48,700
– –
2021 Q2
6 quarters
EOLS icon
39
Evolus
EOLS
$469M
$5.36M 0.47%
+713,774
New +$5.53M
2022 Q4
0 quarters
INCY icon
40
Incyte
INCY
$22.9B
$5.14M 0.45%
+63,996
New +$4.9M
2022 Q4
0 quarters
GH icon
41
Guardant Health
GH
$21.3B
$3.97M 0.35%
146,129
-25,352
-15% -$1.16M
2021 Q1
7 quarters
AMRN icon
42
Amarin Corp
AMRN
$239M
$3.97M 0.35%
164,206
-433,931
-73% -$10.4M
2018 Q1
19 quarters
MRUS icon
43
DELISTED
Merus
MRUS
$2.86M 0.25%
184,556
-92,117
-33% -$1.62M
2021 Q4
4 quarters
JBIO icon
44
Jade Biosciences
JBIO
$857M
$2.67M 0.23%
+2,607
New +$1.89M
2022 Q4
0 quarters
PLRX icon
45
Pliant Therapeutics
PLRX
$55.7M
$2.66M 0.23%
137,423
-156,680
-53% -$3.28M
2022 Q3
1 quarter
CABA icon
46
Cabaletta Bio
CABA
$239M
$2.62M 0.23%
282,874
-277,592
-50% -$1.01M
2022 Q3
1 quarter
BHVN icon
47
Biohaven
BHVN
$1.63B
$2.58M 0.23%
+185,595
New +$2.62M
2022 Q4
0 quarters
TEVA icon
48
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
$2.49M 0.22%
272,900
– –
2021 Q2
6 quarters
IQV icon
49
IQVIA
IQV
$43.9B
$2.23M 0.2%
10,889
+2,592
+31% +$526K
2020 Q4
8 quarters
A icon
50
Agilent Technologies
A
$48.8B
$1.78M 0.16%
11,878
-9,643
-45% -$1.38M
2020 Q4
8 quarters
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Eversept Partners held 85 positions worth $1.14B, down 1% from $1.15B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Eversept Partners deployed $77.2M of net new capital in Q4 2022, opening 15 new positions and adding to 23 existing holdings. Its largest new stake was CATALENT, INC.: 691,677 shares worth $31.1M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 72% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Community Health Systems, an estimated $21M trimmed.

  • Eversept Partners's largest Q4 2022 buy was CATALENT, INC.: 691,677 shares worth $31.1M.
  • Eversept Partners added most to Natera in Q4 2022, an estimated $51.9M increase.
  • Eversept Partners's biggest Q4 2022 reduction was Community Health Systems, cutting an estimated $21M.
  • Eversept Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $96.3M.
  • Eversept Partners's ten largest holdings make up 64% of its $1.14B portfolio in Q4 2022.
  • Eversept Partners opened 15 new positions and closed 17 in Q4 2022.
  • Eversept Partners's portfolio value fell 1% quarter-over-quarter to $1.14B.

Based on Eversept Partners's 13F filing for Q4 2022, filed 14 Feb 2023.